What motivates men age ≥50 years to participate in a screening program for melanoma?

被引:26
作者
Janda, Monika
Youl, Philippa H.
Lowe, John B.
Baade, Peter D.
Elwood, Mark
Ring, Ian T.
Aitken, Joanne F.
机构
[1] Viertel Ctr Res Canc Control, Queensland Canc Fund, Brisbane, Qld, Australia
[2] Queensland Univ Technol, Sch Publ Hlth, Brisbane, Qld, Australia
[3] Univ Iowa, Coll Publ Hlth, Dept Community & Behav Hlth, Iowa City, IA USA
[4] Natl Canc Control Initiat, Carlton, Vic, Australia
[5] Univ Wollongong, Ctr Hlth Serv Dev, Wollongong, NSW 2500, Australia
[6] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia
关键词
melanoma; screening; early detection; skin cancer; middle aged men; elderly men; SKIN SELF-EXAMINATION; AMERICAN-ACADEMY; THICK MELANOMA; POPULATION; PREVALENCE; MORTALITY; CLINICS; PEOPLE;
D O I
10.1002/cncr.22051
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. The screening behavior and screening outcomes of men age >= 50 years was investigated within a randomized controlled trial of a community-based intervention of screening for melanoma, consisting of a community education program, an education program for medical practitioners, and the provision of dedicated skin-screening clinics. METHODS. Data from cross-sectional telephone surveys before (559 completed interviews), at the end (591 completed interview), and at 2 years after the intervention (445 completed interviews) were analyzed. In addition, the authors analyzed data from skin-screening clinics within the intervention program (3355 men age >= 50 years participated). RESULTS. During the intervention period men age >= 50 years increased both their screening behavior and intention to screen. Those men age >= 50 years who reported a past history of removal of a mole as well as other risk factors for skin cancer and positive attitudes toward screening were more likely to participate in skin screening across time. Men age >= 50 years accounted for 20.5% of all skin-screening clinic attendees, 31.3% of those referred for a suspicious lesion, 48.5% of melanomas, and 45% of all keratinocyte carcinomas diagnosed within the screening program, respectively. CONCLUSIONS. The intervention program successfully motivated men age >= 50 years to attend screening for skin cancer, resulting in the highest yield of skin cancer within this subgroup of the population. Messages addressing skin cancer risk factors and attitudes toward skin cancer and screening could be used to target a screening program for melanoma toward men age >= 50 years.
引用
收藏
页码:815 / 823
页数:9
相关论文
共 37 条
[1]  
*AIHW AACR, 2004, CANC AUSTR 2001
[2]   Increase in skin cancer screening during a community-based randomized intervention trial [J].
Aitken, JF ;
Youl, PH ;
Janda, M ;
Lowe, JB ;
Rings, IT ;
Elwood, M .
INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (04) :1010-1016
[3]   Clinical outcomes from skin screening clinics within a community-based melanoma screening program [J].
Aitken, JF ;
Janda, M ;
Elwood, M ;
Youl, PH ;
Ring, IT ;
Lowe, JB .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (01) :105-114
[4]   Prevalence of whole-body skin self-examination in a population at high risk for skin cancer (Australia) [J].
Aitken, JF ;
Janda, M ;
Lowe, JB ;
Elwood, M ;
Ring, IT ;
Youl, PH ;
Firman, DW .
CANCER CAUSES & CONTROL, 2004, 15 (05) :453-463
[5]   A randomised trial of population screening for melanoma [J].
Aitken, JF ;
Elwood, JM ;
Lowe, JB ;
Firman, DW ;
Balanda, KP ;
Ring, IT .
JOURNAL OF MEDICAL SCREENING, 2002, 9 (01) :33-37
[6]  
*AM CANC SOC, 2006, CAN MEL FOUND EARL
[7]  
Balch Charles M, 2003, Semin Surg Oncol, V21, P43, DOI 10.1002/ssu.10020
[8]   An evidence-based staging system for cutaneous melanoma [J].
Balch, CM ;
Soong, SJ ;
Atkins, MB ;
Buzaid, AC ;
Cascinelli, N ;
Coit, DG ;
Fleming, ID ;
Gershenwald, JE ;
Houghton, A ;
Kirkwood, JM ;
McMasters, KM ;
Mihm, MF ;
Morton, DL ;
Reintgen, DS ;
Ross, MI ;
Sober, A ;
Thompson, JA ;
Thompson, JF .
CA-A CANCER JOURNAL FOR CLINICIANS, 2004, 54 (03) :131-149
[9]   Screening for skin cancer - Recommendations and rationale [J].
Berg, AO ;
Allan, JD ;
Frame, PS ;
Homer, CJ ;
Lieu, TA ;
Mulrow, CD ;
Orleans, CT ;
Peipert, JF ;
Pender, NJ ;
Sox, HC ;
Teutsch, SM ;
Westhoff, C ;
Woolf, SH .
AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2001, 20 (03) :44-46
[10]   Nodular histogenetic type - the most significant factor for thick melanoma: implications for prevention [J].
Bergenmar, M ;
Ringborg, U ;
Brahme, EM ;
Brandberg, Y .
MELANOMA RESEARCH, 1998, 8 (05) :403-411